Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French recall of Abbott AxSYM and IMx lots:

This article was originally published in Clinica

Executive Summary

Abbott Diagnostics has recalled certain lots of its AxSYM and IMx in vitro diagnostic products on the French market. The recall, says the French healthcare products safety agency, AFSSAPS, affects lots 89273M300 and 89470M200 of its AxSYM (reference number 3C79-20) and lots 75782M200 and 75998M200 of its IMx (reference number 2200-20). These products are involved in the dosification of vitamin B12 in serum and plasma.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT067548

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel